Login / Register The Most Trusted Name in Medical Education


Elsevier's Office of CME offers a variety of courses for the nursing community.

Newborn image 1

Mosby's Essential Nursing CE: Newborn Series

Format: eLearning Activity

Mosby's Essential Nursing CE Newborn Series, sponsored by an educational grant from Mead Johnson Nutrition, is authored and peer reviewed by nurse experts. The four web-based, interactive, multimedia lessons are designed for perinatal nurses, and include a printable Lesson Notebook that is a detailed lesson outline for personal note taking. Elsevier provides the continuing education contact hours.* 

  1. Care of the Stable Newborn -  0.62 contact hours
  2. Newborn and Infant Nutrition -   0.71 contact hours
  3. Newborn Physiology -  0.54 contact hours
  4. Physical Assessment of the Newborn -  0.81 contact hours
*Elsevier is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Elsevier is provider approved by the Florida Board of Nursing. The provider number is #50-4681. Elsevier is provider approved by the California Board of Registered Nursing. The provider number is CEP 3257.

Click here to register and start earning free contact hours.


910687 116x140

Severe Asthma and the Primary Care Provider: Identifying Patients and Coordinating Multidisciplinary Care

Format: Webcast

This CME-accredited Through Your Patient’s EyesTM program is intended for primary care providers and other clinicians who manage patients with asthma. This educational activity has been designed to highlight issues faced by people living with asthma, including patients’ perspectives on the burdens of severe disease, difficulties related to suboptimal health literacy, and potential hurdles that can arise in busy healthcare practices. Specialist and primary care faculty discuss practical advice on overcoming these challenges, how to best coordinate multidisciplinary care, and actionable recommendations on identifying, comprehensively assessing, and longitudinally managing patients with severe asthma. As a result, clinician learners will be better prepared to engage and educate their patients with severe asthma, while improving long-term outcomes through personalized evidence-based care.  

Take Course »


Credits: 1.00 AMA PRA Category 1 Credit(s)™ or 1.00 Nursing Contact Hours
910645 116 x 140

An Update on Scientific Advances and Clinical Strategies in Alzheimer’s Disease: Report from AAIC 2016

Format: Medical Meeting Reporter

The Alzheimer's Association International Conference® 2016 (AAIC®) annual meeting was held in Toronto, Canada, July 22-28, 2016. AAIC is the world's largest forum for the dementia research community. Researchers, clinicians, care providers, and students from more than 70 countries gather at AAIC to network and discuss the latest dementia study results, theories, and discoveries. In this activity, 2 experts summarize the key learnings from this year’s conference.

Register »

Credits: 0.75 AMA PRA Category 1 Credit(s)™ or 0.75 AANP Contact Hour(s)
ESC 116 x 140

ESC 2016: Utilizing PCSK9 Therapies for Better Long-Term Outcomes in Dyslipidemia Patients

Format: Medical Meeting Reporter

This CME Program will highlight information presented at the European Society of Cardiology Congress 2016 held in Rome, Italy on August 27-31, 2016. Didactic presentation in combination with intermittent, interactive panel discussions will provide clinicians with a better understanding of the pathophysiology of hypercholesterolemia, including approaches for prevention and assessment of risk. Three expert faculty will decipher recent clinical trial data and communicate new treatment strategies, including those centered around PCSK9 usage, as well as best practices for patients with dyslipidemia. Discussion about the role and importance of the comprehensive healthcare team will ensue. Upon completing this program, clinicians responsible for the management of patients with dyslipidemia will be better equipped with the most up-to-date information to create tailored treatment plans and optimize patient outcomes.

Register »

Credits: 1.00 AMA PRA Category 1 Credit(s)™ or 1.0 AANP Contact Hour(s)
910670 116 x 140

ECTRIMS 2016: Utilizing Individualized Treatment Plans to Optimally Manage Patients with Multiple Sclerosis

Format: Medical Meeting Reporter

This CME program will focus on the new and emerging therapeutic options for the management of patients with multiple sclerosis (MS) that were discussed at the 2016 ECTRIMS Annual Meeting in London, United Kingdom from September 14 – 17, 2016. This activity will educate healthcare providers about novel techniques and optimal management strategies for their patients with multiple sclerosis. The expert faculty will discuss the science behind new and emerging therapies, the efficacy and safety data supporting new biomarkers, and the role of biomarkers alongside traditional MS treatment options. Upon completion of this CME activity, the multidisciplinary team will be equipped with the information needed to create tailored treatment plans and improve outcomes.

Register »

Credits: 1.00 AMA PRA Category 1 Credit(s)™
910655 116 x 140

Applying Recent Advances in the Science of CFTR-based Therapeutics to Improve Outcomes in Patients With Cystic Fibrosis

Format: Webcast

The content for this activity is based on the satellite symposium, “Applying Recent Advances in the Science of CFTR-based Therapeutics to Improve Outcomes in Patients With Cystic Fibrosis”, that was presented at the 30th Annual North American Cystic Fibrosis Conference in Orlando, Florida on October 28, 2016. The content highlights the latest advancements, particularly in CFTR-based therapeutics, for the treatment of patients with cystic fibrosis. Expert faculty discuss the most up-to-date analysis for clinical decision-making, including updates on assessment, monitoring, and management of patients treated with CFTR modulator therapies. The goal of this activity is to increase the knowledge and competencies of the multidisciplinary team involved in the management of patients with CF, and provide strategies for improving the lives of patients. Upon completion of this activity, healthcare providers will be better equipped with imperative information for creating more effective personalized treatment plans and improving patient outcomes.

Register »

Credits: 2.00 AMA PRA Category 1 Credit(s)™
910666 116 x 140

Where Are We Now? A Clinicians’ Guide to the Use of Follow-on Insulin for Patients with Diabetes

Format: Webcast

Insulin has been used as a standard treatment for patients with diabetes for almost 100 years.  Over time, advances in insulin development have improved its pharmacologic properties.  Most recently, the US Food and Drug Administration approved a novel, follow-on basal insulin agent, with more expected to be commercially available in the near future. With the imminent availability of follow-on basal insulin agents, clinicians need to be aware of the potential benefits and concerns in order to facilitate informed decision making and to provide the best possible advice and guidance to their patients with diabetes.  This program will review how follow-on insulin products are developed, manufactured, and receive regulatory approval; evaluate clinical trial data for new and emerging follow-on basal insulin agents; and provide practical information and guidance on how they may be incorporated into clinical practice.  While it is unknown how follow-on basal insulins will affect patient outcomes, they have the potential to increase access to treatment among patients with diabetes and reduce healthcare costs.

Take Course »

Credits: 1.25 AMA PRA Category 1 Credit(s)™ or 1.25 Nursing Contact Hours
910561 125 x 125

REMS Update 2017: Risk Evaluation and Mitigation Strategy

Format: Webcast

This educational supplement has been created to educate healthcare professionals on the safe and proper use of Extended-Release (ER) and Long-Acting (LA) opioids for chronic pain management. Opioids are the cornerstone of modern pain management. They are highly complex molecules which require knowledge and integration of basic science, clinical, pharmacological, psychosocial, abuse, diversion, and public health aspects of opioids. This Opioid Risk Evaluation and Mitigation Strategy (REMS) supplement is a valuable tool that can be utilized daily by everyone in your practice. Continuing Medical Education (CME/CE) credits are available for studying this supplement and completing the online test. The supplement and test can be completed in a little more than three hours, but it will have a lifetime benefit!

Take Course »

Credits: 3.00 AMA PRA Category 1 Credit(s)™ or 3.0 Nursing Contact Hours

Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability

Format: Webcast

Effective treatment of major depressive disorder with antidepressants is currently limited by factors that affect treatment compliance, including delay in onset of therapeutic effects and, often, intolerable side-effects. Recent data suggest that use of antidepressant combinations with different mechanisms of action may be a better first-line strategy prior to augmentation with other drug classes. The rationale for this approach is that combining multiple pharmacological actions affecting multiple monoamine targets produces greater efficacy. The latest data on multimodal therapies indicate shorter onset of therapeutic effects and improved tolerability. By modulating multiple receptors and neurotransmitter systems, it is hoped that these new agents may also treat some of the associated symptoms of major depressive disorder, such as anxiety and cognitive dysfunction.


Credits: 3.0 AMA PRA Category 1 Credits™